Compugroup Medical Se Stock Analysis
CMPVF Stock | USD 18.04 0.00 0.00% |
CompuGroup Medical SE is fairly valued with Real Value of 18.04 and Hype Value of 18.04. The main objective of CompuGroup Medical pink sheet analysis is to determine its intrinsic value, which is an estimate of what CompuGroup Medical SE is worth, separate from its market price. There are two main types of CompuGroup Medical's stock analysis: fundamental analysis and technical analysis.
The CompuGroup Medical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CompuGroup Medical's ongoing operational relationships across important fundamental and technical indicators.
CompuGroup |
CompuGroup Pink Sheet Analysis Notes
About 50.0% of the company shares are held by company insiders. The book value of CompuGroup Medical was currently reported as 12.87. The company last dividend was issued on the 20th of May 2022. CompuGroup Medical had 25:1 split on the 23rd of October 2006. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugoup Med is traded on OTC Exchange in the United States.The quote for CompuGroup Medical SE is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CompuGroup Medical SE please contact the company at 49 261 8000 0 or go to https://www.cgm.com.CompuGroup Medical Investment Alerts
CompuGroup Medical generated a negative expected return over the last 90 days | |
CompuGroup Medical SE has accumulated 587.08 M in total debt with debt to equity ratio (D/E) of 1.32, which is about average as compared to similar companies. CompuGroup Medical has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CompuGroup Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CompuGroup Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CompuGroup Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CompuGroup to invest in growth at high rates of return. When we think about CompuGroup Medical's use of debt, we should always consider it together with cash and equity. | |
About 50.0% of CompuGroup Medical shares are held by company insiders |
CompuGroup Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CompuGroup Medical's market, we take the total number of its shares issued and multiply it by CompuGroup Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.CompuGroup Profitablity
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.Technical Drivers
CompuGroup Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.CompuGroup Medical Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CompuGroup Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CompuGroup Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About CompuGroup Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how CompuGroup Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CompuGroup shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as CompuGroup Medical. By using and applying CompuGroup Pink Sheet analysis, traders can create a robust methodology for identifying CompuGroup entry and exit points for their positions.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugoup Med is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding CompuGroup Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
All Next | Launch Module |
Complementary Tools for CompuGroup Pink Sheet analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |